APA

Palova M., Szotkowski T., Hlusi A., Indrak K., Navratilova J., Divoka M. & Papajik T. (20190626). Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center. : Neoplasma.

Chicago

Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M and Papajik T. 20190626. Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center. : Neoplasma.

Harvard

Palova M., Szotkowski T., Hlusi A., Indrak K., Navratilova J., Divoka M. and Papajik T. (20190626). Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center. : Neoplasma.

MLA

Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M and Papajik T. Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center. : Neoplasma. 20190626.